Home Newsfeeds Barclays Maintains Overweight on Gossamer Bio, Raises Price Target to $18

Barclays Maintains Overweight on Gossamer Bio, Raises Price Target to $18

Barclays analyst Carter Gould maintains Gossamer Bio (NASDAQ:GOSS) with a Overweight and raises the price target from $12 to $18.

byBenzinga Newsdesk

August 18, 2022

1 minute read

Barclays analyst Carter Gould maintains Gossamer Bio (NASDAQ:GOSS) with a Overweight and raises the price target from $12 to $18.

Textainer Boosts Quarterly Common Dividend By 20% To $0.30 From $0.25 Per Share

By Benzinga Newsdesk

February 14, 9:05 AM

Textainer's board of directors approved and declared a $0.30 per common share cash dividend, payable on March 15, 2023 to holders of record as of March 3, 2023, an increase of $0.05 per common

TGH

Needham Maintains Buy on Workday, Raises Price Target to $220

By Benzinga Newsdesk

August 26, 6:30 AM

Needham analyst Scott Berg maintains Workday (NASDAQ:WDAY) with a Buy and raises the price target from $200 to $220.

WDAY

How To Earn $500 A Month From American Eagle Stock After Better-Than-Expected Earnings

By Priya Nigam

September 7, 9:13 AM

American Eagle Outfitters, Inc. (NYSE: AEO) reported better-than-expected earnings for its second quarter and raised its FY2024 operating income guidance.

AEO

What Does Kimberly-Clark’s Debt Look Like?

By Benzinga Insights

December 7, 1:14 PM

Over the past three months, shares of Kimberly-Clark Inc. (NYSE:KMB) increased by 7.82%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.

KMB

Barclays Maintains Overweight on Gossamer Bio, Raises Price Target to $18

Related Posts

Textainer Boosts Quarterly Common Dividend By 20% To $0.30 From $0.25 Per Share

Needham Maintains Buy on Workday, Raises Price Target to $220

How To Earn $500 A Month From American Eagle Stock After Better-Than-Expected Earnings

What Does Kimberly-Clark’s Debt Look Like?